Saracatinib in Treating Patients With Prostate Cancer

Summary

This randomized phase II clinical trial is studying how well saracatinib works in treating patients with prostate cancer. Saracatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2010-12

Primary completion

2012-09

Completion

2013-11

Drugs

Indications